BioSpace News Archive

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that President and Chief Executive Officer Jon Serbousek and Chief Financial Officer Doug Rice will be presenting during the upcoming Sidoti Virtual Investor Conference on Wednesday, September 21, 2022 at 10:00 a.m. ET.

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, provided an update on activities related to the commercial introduction of its EVO Visian® Implantable Collamer® Lenses in the U.S. EVO is an FDA-approved vision correction lens designed for the correction/reduction of myopia with and without astigmatism.

Aptose Biosciences Inc. today announced that the Aptose will be participating in the Cantor Oncology, Hematology & HemeOnc Conference on September 28, 2022.

Probius, a deep tech company bridging the data gap between biology and AI, today announced the expansion of their leadership team.

Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today key updates from the International Surgical Sleep Society (ISSS) and American Academy of Otolaryngology (AAO-HNSF) meetings which took place in Philadelphia September 9-14th.

The American Gastroenterological Association launched Trust Your Gut, an awareness campaign aimed at shortening the time from the onset of bowel symptoms to discussions with a health care provider.

Ovation Science Inc. (“Ovation” or the “Company”), a topical and transdermal cannabis product development company with a patented skin delivery technology Invisicare®, is pleased to announce that the U.S. Patent and Trademark Office (USPTO) has granted Ovation a patent entitled “Composition and Method for Transdermal Delivery of Cannabidiol (CBD) and 9-Tetrahydrocannabinol (THC)"; (US Patent Number: 11,439,602), with an expiry of February 2041.

Prometheus Laboratories Inc. (“Prometheus”) today announced its partnership with Takeda Pharmaceutical Company Limited (“Takeda”) to nationally launch CDPATH, an innovative prognostic tool for Crohn’s disease (CD) patients.

Dunad Therapeutics, a biopharmaceutical company developing small molecule covalent therapies based on novel insights from chemistry and protein degradation, today announced the hire of Ruben Tommasi, Ph. D., as Chief Research and Development Officer.

Cardiac Implants LLC has announced the successful initial deployment of its Annuloplasty ring with implementation of a therapeutic adjustment procedure using its innovative Tri-Ring™ percutaneous annuloplasty device.